NCT00060151View on ClinicalTrials.gov

GW786034 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2002

Study Completion Date

June 30, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pazopanib hydrochloride

Trial Locations (2)

27710

Duke Comprehensive Cancer Center, Durham

44106-5065

Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00060151 - GW786034 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter